Significantly, we demonstrated that by blocking the NFAT3/FasL signaling axis, we were able to alleviate NIHL, highlighting the potential of this pathway as a novel target for the prevention and treatment of NIHL (Figure 10). This evidence concerns the gene NFATC4 and noise induced hearing loss.